Alert October 23, 2006

Recent Developments at Goodwin Procter

Conferences, Seminars and Speaking Engagements

Patent Litigation
Date: November 6, 2006
Location: Practising Law Institute, New York, NY
Elaine Blais will participate in the panel entitled “The Paper Side of Jury Litigation: Instructions, Special Interrogatories, Motions Special to Jury Practice.”

MIT $100K Competition – IP Seminar
Date: October 26, 2006
Location: MIT, Cambridge, MA
This is an IP-focused panel hosted by the $100K competition organizers for entrants. The seminar will give entrants general IP information as well as guidelines for navigating the patent process. Duncan Greenhalgh will participate in this session.

Monetizing Intellectual Property
Date: October 12, 2006
Location: Goodwin Procter Offices, Boston and New York
This internally-produced seminar is part of the Securitizations and Derivatives CLE Seminar Series and covered: road map of the IP securitization market; securitizable intellectual property and royalties and special issues for certain asset classes. Mitch Bloom and Kingsley Taft presented this session.

 

Publications

Jacqueline Klosek and Kendrick Nguyen published “French Solidarity Tax: Providing Access to Medicine Without Compromising IP Rights,” in Global Intellectual Property Asset Management Report.

Stephen Charkoudian published “Establishing a Patent Licensing Programme,” in Licensing in the Boardroom, August 2006.

Ira Levy was interviewed by The Wall Street Transcript, July 2006.

Jacqueline Klosek published “Second Draft of GPLv3 Is Released and Concerns Are Raised,” in World Copyright Law Report, June 8, 2006.

Jacqueline Klosek and Kendrick Nguyen published “Vendor Management: A Critical Component of Privacy Compliance,” in The Privacy Advisor, June 2006.

 

Client Service

Aegerion Pharmaceuticals, Inc.
Cross-license relationship with Pfizer Inc. and the University of Pennsylvania to independently pursue product development opportunities involving microsomal triglyceride transfer protein-based (MTP) therapies as potential treatments to reduce LDL cholesterol. Duncan Greenhalgh, Edmund Pitcher, Kingsley Taft.